EUVIMEDEUVIMED entdecken
Open Access · CC BY-ND 4.0

Clinical case of autoimmune polyendocrine syndrome type IIIA: analysis of diagnostic and treatment stages

A. V. Kedyk, L. K. Sokolova, O. O. Kutsyn

Clinical Endocrinology and Endocrine Surgery · 30.06.2026 · (2) · 90-98

DOI: 10.30978/cees-2026-2-90 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology and Endocrine Surgery, online erschienen am 30.06.2026. Verfasst von A. V. Kedyk und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune polyendocrine syndrome type III (APS III) is characterized by a combination of autoimmune thyroid diseases with other organ-specific immune-mediated pathologies without the involvement of the adrenal glands. APS subtype IIIA is characterized by the association of chronic autoimmune thyroiditis or Graves’ disease with concomitant endocrine disorders, most often type 1 diabetes mellitus. The development of type 1 diabetes mellitus following the onset of Graves’ disease is an atypical sequence for APS III A. Timely diagnosis of autoimmune conditions is often complicated by overlapping symptomatology and iatrogenic factors during patient management. Objective — to describe a clinical case of autoimmune polyendocrine syndrome type III A and analyze the stages of diagnosis and treatment to optimize the management strategy for such patients. The results of a comprehensive clinical, laboratory, and instrumental examination of a 25-year-old woman are presented. The diagnostic algorithm included the assessment of the thyroid panel, ultrasound examination of the thyroid gland, study of carbohydrate metabolism markers (fasting glucose, glycated hemoglobin), specific antibodies to glutamate decarboxylase, C-peptide level, as well as screening for celiac disease and iron deficiency. A continuous glucose monitoring system was used to control glycemic indices. In a patient with a 2-year history of Graves’ disease, after a course of thiamazole and radioiodine therapy, a relapse of thyrotoxicosis was detected against the background of persistently elevated thyroid-stimulating antibody titers. Laboratory parameters 10 months after radioiodine therapy demonstrated TSH suppression (< 0.005 mIU/ L), elevated fT3 (5.47 pg/ mL) and fT4 (1.6 ng/ dL), as well as a high titer of TRAb (20.2 IU/ L) with a total gland volume of 20.5 cm³. Additionally, pronounced hyperglycemia was diagnosed (fasting 9.5 mmol/L, HbA1c 8.12%). The detection of a critically high titer of antibodies to glutamate decarboxylase (GADA > 280 IU/mL) and decreased C-peptide (0.5 ng/mL) allowed confirmation of new-onset autoimmune diabetes, which confirmed the presence of APS III A. The patient’s thyrostatic therapy was optimized (thiamazole 20 mg/day) and basal-bolus insulin therapy was initiated. After 6 weeks, normalization of the thyroid status and target glycemic control was achieved (time in range was 91%, glycemic variability — 30%). Conclusions. The combination of Graves’ disease and type 1 diabetes mellitus in young individuals demonstrates a rare sequence in the development of APS III A components. Radioiodine therapy and concomitant short-term use of glucocorticoids are not considered direct triggers of autoimmune diabetes, but they can mask or exacerbate its clinical manifestations. Premature prescription of hormone replacement therapy without laboratory confirmation of persistent hypothyroidism after radioiodine therapy complicates the timely diagnosis of a thyrotoxicosis relapse. Management of such patients requires active diagnostic evaluation, routine screening of specific autoantibodies, and a multidisciplinary approach with the early involvement of continuous glucose monitoring technologies.

Zitieren

APA

Kedyk, A. V., Sokolova, L. K., & Kutsyn, O. O. (2026). Clinical case of autoimmune polyendocrine syndrome type IIIA: analysis of diagnostic and treatment stages. Clinical Endocrinology and Endocrine Surgery, 90-98. https://doi.org/10.30978/cees-2026-2-90

Vancouver

Kedyk AV, Sokolova LK, Kutsyn OO. Clinical case of autoimmune polyendocrine syndrome type IIIA: analysis of diagnostic and treatment stages. Clinical Endocrinology and Endocrine Surgery. 2026:90-98. doi:10.30978/cees-2026-2-90

BibTeX
@article{Kedyk2026,
  author = {Kedyk, A. V. and Sokolova, L. K. and Kutsyn, O. O.},
  title = {Clinical case of autoimmune polyendocrine syndrome type IIIA: analysis of diagnostic and treatment stages},
  journal = {Clinical Endocrinology and Endocrine Surgery},
  year = {2026},
  number = {2},
  pages = {90--98},
  doi = {10.30978/cees-2026-2-90}
}
Kostenlos starten →